Skip to content

13F-HR filed by Healthcare Value Capital, LLC

Healthcare Value Capital, LLC filed this 13F-HR for the quarter ended 2015-03-31, filed 2015-05-14, with 36 holding rows worth $91,752,000.

Accession
0000919574-15-004046
Filed
2015-05-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2015

A holdings report, 36 entries on the cover page, a total value of $91,752,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $91,756,000 with VALUE read as thousands by filing date, 13F file number 028-14998. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ASTRAZENECA PLC SPONSORED ADR046353108ADR150,000$10,265,000thousands by filing datecall
ALBANY MOLECULAR RESH012423109COMMON STOCK542,400$9,546,000thousands by filing date
PROSHARES TR74348A319ULTSHT RUSS2000200,000$7,120,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR100,000$6,843,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR100,000$6,230,000thousands by filing date
QUEST DIAGNOSTICS INC COM74834L100Stock77,208$5,933,000thousands by filing date
Pfizer Inc.717081103COM150,000$5,219,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW50,000$3,856,000thousands by filing date
QLT INC746927102COMMON STOCK912,200$3,567,000thousands by filing date
PROSHARES TR ULTSH NASD BIOT74347B789CEF100,000$3,450,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR65,000$3,214,000thousands by filing datecall
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR50,000$3,115,000thousands by filing datecall
ACTAVIS PLCG0083B108SHS10,000$2,976,000thousands by filing date
MANNKIND CORP56400P201COM500,000$2,600,000thousands by filing dateput
ARTIVION INC228903100COM221,000$2,292,000thousands by filing date
ALBANY MOLECULAR RESH012423109COMMON STOCK120,000$2,112,000thousands by filing datecall
SORRENTO THERAPEUTICS INC83587F202COMMON STOCK125,000$1,445,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM150,000$1,236,000thousands by filing date
Alliqua BioMedical Inc019621200COM NEW196,000$1,019,000thousands by filing date
APRICUS BIOSCIENCES INC03832V109COM500,000$935,000thousands by filing date
PROSHARES TR ULTSH NASD BIOT74347B789CEF25,000$863,000thousands by filing datecall
ARIAD PHARMACEUTICALS INC04033A100COM100,000$824,000thousands by filing datecall
FIBROCELL SCIENCE INC315721209COM NEW157,769$712,000thousands by filing date
ZOGENIX INC98978L105COM500,000$685,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW100,000$678,000thousands by filing date
AEGERION PHARMACEUTICALS INC00767E102COM25,000$654,000thousands by filing date
QLT INC746927102COMMON STOCK150,000$587,000thousands by filing datecall
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK150,000$536,000thousands by filing date
ALIMERA SCIENCES INC016259103COM100,000$501,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW200,000$490,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW200,000$490,000thousands by filing datecall
AMARIN CORP PLC023111206SPONS ADR NEW200,000$468,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW200,000$468,000thousands by filing datecall
STEMLINE THERAPEUTICS INC85858C107COM25,000$362,000thousands by filing date
ALIMERA SCIENCES INC016259103COM50,000$251,000thousands by filing datecall
CELSION CORPORATION COM PAR15117N404Stock80,000$214,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-15-004046this filing2015-05-14acceptance time not in the bulk data set